Valuation: Enzymatica AB

Market Cap 583M 510M 471M 439M 827M 55.08B 842M 5.65B 2.19B 27.18B 2.19B 2.14B 94.69B P/E 2024
-5.73x
P/E 2025 -8.89x
Enterprise Value 550M 482M 445M 415M 782M 52.05B 796M 5.34B 2.07B 25.68B 2.07B 2.02B 89.47B EV / Sales 2024
5.88x
EV / Sales 2025 7.96x
Free-Float
56.66%
Yield 2024 *
-
Yield 2025 -
1 day-2.50%
Current month-2.50%
1 month-13.33%
3 months-22.00%
6 months+21.88%
Current year+23.16%
1 week 2.27
Extreme 2.27
2.64
1 month 2
Extreme 2
2.89
Current year 1.6
Extreme 1.6
3.4
1 year 1.6
Extreme 1.6
3.4
3 years 1.34
Extreme 1.34
5.45
5 years 1.34
Extreme 1.34
13.4
10 years 1.34
Extreme 1.34
24.7
Manager TitleAgeSince
Chief Executive Officer - 31/01/2026
Chief Operating Officer 61 31/12/2010
Director of Finance/CFO - 12/04/2026
Director TitleAgeSince
Chairman 58 14/02/2016
Chairman 64 18/12/2016
Director/Board Member 71 18/12/2016
Date Insider Type Main position Quantity % Market Cap.
03-31Sell

Responsable ventes & marketing

40,000 0.0165%
12-29Buy

Chairman

20,000 0.0082%
12-26Buy

Chairman

10,000 0.0041%
Change 5-day change 1-year change 3-year change Capi.($)
-0.42%0.00%-9.30%-9.13% 60.11M
-2.48%+8.34%+53.87%+155.75% 1,070B
-1.76%+6.23%+66.27%+53.44% 611B
-1.05%+7.19%+35.57%+86.77% 445B
-2.13%+4.18%+31.11%+23.88% 329B
+0.16%+1.34%+35.51%+35.88% 290B
-0.74%+1.05%+28.34%+41.90% 287B
+0.87%+1.78%-27.66%-41.42% 213B
+0.44%+4.35%+29.69%+63.10% 195B
+0.01%+1.03%+13.95%+63.93% 157B
Average -0.37%+5.81%+25.73%+47.41% 359.63B
Weighted average by Cap. -0.20%+6.67%+40.23%+78.32%

Financials

2024 2025
Net sales 45.58M 39.89M 36.82M 34.35M 64.72M 4.31B 65.88M 442M 171M 2.13B 171M 167M 7.41B 53.9M 47.18M 43.55M 40.63M 76.55M 5.1B 77.92M 522M 203M 2.51B 203M 198M 8.76B
Net income -53.18M -46.55M -42.97M -40.08M -75.52M -5.03B -76.87M -515M -200M -2.48B -200M -195M -8.64B -51.89M -45.42M -41.93M -39.11M -73.69M -4.91B -75.01M -503M -195M -2.42B -195M -191M -8.43B
Net Debt -73.01M -63.91M -58.99M -55.03M -104M -6.9B -106M -708M -275M -3.41B -274M -268M -11.87B -32.11M -28.11M -25.95M -24.2M -45.6M -3.04B -46.42M -311M -121M -1.5B -121M -118M -5.22B
Logo Enzymatica AB
Enzymatica AB (publ) is a Sweden-based life science company that develops and sells medical devices for infection-related diseases. The Company deals with research, development and sales of products based on enzyme technology and related activities. Enzymatica AB (publ) develops solutions that support the body's own defenses against virus, irritants and microorganisms. The Company offers products which are based on a barrier technology, includes marine enzymes. Enzymatica AB (publ) focuses on product development based on the tested and patented barrier technology used in the common cold product ColdZyme, a mouth spray that protects against colds, can help shorten the duration of the cold if used in the early stages of infection, relieves cold symptoms, and soothes sore throats.
Employees
21
Date Price Change Volume
01/07/26 SEK 2.390 -0.42% 20,451
30/06/26 SEK 2.400 -4.38% 155,436
29/06/26 SEK 2.510 +0.40% 26,680
26/06/26 SEK 2.500 +8.70% 209,094
25/06/26 SEK 2.300 -1.71% 28,440

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENZY Stock